Literature DB >> 20807646

Endothelial heparan sulfate in angiogenesis.

Mark M Fuster1, Lianchun Wang.   

Abstract

Heparan sulfate (HS) is a linear polysaccharide composed of 50-200 glucosamine and uronic acid (glucuronic acid or iduronic acid) disaccharide repeats with epimerization and various sulfation modifications. HS is covalently attached to core proteins to form HS-proteoglycans. Most of the functions of HS-proteoglycans are mediated by their HS moieties. The biosynthesis of HS is initiated by chain polymerization and is followed by stepwise modification reactions, including sulfation and epimerization. These modifications generate ligand-binding sites that modulate cell functions and activities of proteinases and/or proteinase inhibitors. HS is abundantly expressed in developing and mature vasculature, and understanding its roles in vascular biology and related human diseases is an area of intense investigation. In this chapter, we summarize the significant recent advances in our understanding of the roles of HS in developmental and pathological angiogenesis with a major focus on studies using transgenic as well as gene knockout/knockdown models in mice and zebrafish. These studies have revealed that HS critically regulates angiogenesis by playing a proangiogenic role, and this regulatory function critically depends on HS fine structure. The latter is responsible for facilitating cell-surface binding of various proangiogenic growth factors that in turn mediate endothelial growth signaling. In cancer, mouse studies have revealed important roles for endothelial cell-surface HS as well as matrix-associated HS, wherein signaling by multiple growth factors as well as matrix storage of growth factors may be regulated by HS. We also discuss important mediators that may fine-tune such regulation, such as heparanase and sulfatases; and models wherein targeting HS (or core protein) biosynthesis may affect tumor growth and vascularization. Finally, the importance of targeting HS in other human diseases wherein angiogenesis may play pathophysiologic (or even therapeutic) roles is considered.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20807646      PMCID: PMC3703633          DOI: 10.1016/S1877-1173(10)93009-3

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  138 in total

1.  Drosophila heparan sulfate 6-O-sulfotransferase (dHS6ST) gene. Structure, expression, and function in the formation of the tracheal system.

Authors:  K Kamimura; M Fujise; F Villa; S Izumi; H Habuchi; K Kimata; H Nakato
Journal:  J Biol Chem       Date:  2001-03-08       Impact factor: 5.157

Review 2.  Notch signaling in vascular morphogenesis.

Authors:  Jackelyn A Alva; M Luisa Iruela-Arispe
Journal:  Curr Opin Hematol       Date:  2004-07       Impact factor: 3.284

3.  HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.

Authors:  Keishi Narita; Julie Staub; Jeremy Chien; Kristy Meyer; Maret Bauer; Andreas Friedl; Sundaram Ramakrishnan; Viji Shridhar
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

4.  Heparan sulfate is required for embryonic stem cells to exit from self-renewal.

Authors:  Daniel C Kraushaar; Yu Yamaguchi; Lianchun Wang
Journal:  J Biol Chem       Date:  2009-12-17       Impact factor: 5.157

5.  Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

Authors:  S Soker; S Takashima; H Q Miao; G Neufeld; M Klagsbrun
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

6.  Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate.

Authors:  Martha L Escobar Galvis; Juan Jia; Xiao Zhang; Nadja Jastrebova; Dorothe Spillmann; Eva Gottfridsson; Toin H van Kuppevelt; Eyal Zcharia; Israel Vlodavsky; Ulf Lindahl; Jin-Ping Li
Journal:  Nat Chem Biol       Date:  2007-10-21       Impact factor: 15.040

7.  Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4.

Authors:  F Echtermeyer; M Streit; S Wilcox-Adelman; S Saoncella; F Denhez; M Detmar; P Goetinck
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

8.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

9.  Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1alpha/CXCR4 axis.

Authors:  Nan Song; Yujie Huang; Hubing Shi; Shaopeng Yuan; Yanping Ding; Xiaomin Song; Yan Fu; Yongzhang Luo
Journal:  Cancer Res       Date:  2009-07-07       Impact factor: 12.701

10.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

View more
  37 in total

1.  The C-terminal fragment of axon guidance molecule Slit3 binds heparin and neutralizes heparin's anticoagulant activity.

Authors:  Eduard Condac; Heather Strachan; Gerardo Gutierrez-Sanchez; Benjamin Brainard; Christina Giese; Christian Heiss; Darryl Johnson; Parastoo Azadi; Carl Bergmann; Ron Orlando; Charles T Esmon; Job Harenberg; Kelley Moremen; Lianchun Wang
Journal:  Glycobiology       Date:  2012-05-28       Impact factor: 4.313

2.  Human papillomavirus capsids preferentially bind and infect tumor cells.

Authors:  Rhonda C Kines; Rebecca J Cerio; Jeffrey N Roberts; Cynthia D Thompson; Elisabet de Los Pinos; Douglas R Lowy; John T Schiller
Journal:  Int J Cancer       Date:  2015-10-27       Impact factor: 7.396

3.  Pro-angiogenic effects of pregnancy-specific glycoproteins in endothelial and extravillous trophoblast cells.

Authors:  Shemona Rattila; Florian Kleefeldt; Angela Ballesteros; Jimena S Beltrame; Maria L Ribeiro; Süleyman Ergün; Gabriela Dveksler
Journal:  Reproduction       Date:  2020-11       Impact factor: 3.906

4.  Heparan sulfate deficiency disrupts developmental angiogenesis and causes congenital diaphragmatic hernia.

Authors:  Bing Zhang; Wenyuan Xiao; Hong Qiu; Fuming Zhang; Heather A Moniz; Alexander Jaworski; Eduard Condac; Gerardo Gutierrez-Sanchez; Christian Heiss; Robin D Clugston; Parastoo Azadi; John J Greer; Carl Bergmann; Kelley W Moremen; Dean Li; Robert J Linhardt; Jeffrey D Esko; Lianchun Wang
Journal:  J Clin Invest       Date:  2013-12-20       Impact factor: 14.808

5.  Characterization of heparin-binding site of tissue transglutaminase: its importance in cell surface targeting, matrix deposition, and cell signaling.

Authors:  Zhuo Wang; Russell J Collighan; Kamila Pytel; Daniel L Rathbone; Xiaoling Li; Martin Griffin
Journal:  J Biol Chem       Date:  2012-02-01       Impact factor: 5.157

Review 6.  The role of endothelial mechanosensitive genes in atherosclerosis and omics approaches.

Authors:  Rachel D Simmons; Sandeep Kumar; Hanjoong Jo
Journal:  Arch Biochem Biophys       Date:  2015-12-11       Impact factor: 4.013

Review 7.  Pathological processes activated by herpes simplex virus-1 (HSV-1) infection in the cornea.

Authors:  Lulia Koujah; Rahul K Suryawanshi; Deepak Shukla
Journal:  Cell Mol Life Sci       Date:  2018-10-16       Impact factor: 9.261

8.  HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2.

Authors:  Francesca Caccuri; Cinzia Giagulli; Antonella Bugatti; Anna Benetti; Giulio Alessandri; Domenico Ribatti; Stefania Marsico; Paola Apostoli; Mark A Slevin; Marco Rusnati; Carlos A Guzman; Simona Fiorentini; Arnaldo Caruso
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-17       Impact factor: 11.205

9.  Assignment Of Hexuronic Acid Stereochemistry In Synthetic Heparan Sulfate Tetrasaccharides With 2-O-Sulfo Uronic Acids Using Electron Detachment Dissociation.

Authors:  Isaac Agyekum; Anish B Patel; Chengli Zong; Geert-Jan Boons; Jonathan Amster
Journal:  Int J Mass Spectrom       Date:  2015-11-15       Impact factor: 1.986

Review 10.  Heparan sulfate: a key regulator of embryonic stem cell fate.

Authors:  Daniel C Kraushaar; Stephen Dalton; Lianchun Wang
Journal:  Biol Chem       Date:  2013-06       Impact factor: 3.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.